{"id": "1366810539704295425", "creation": 1614708001.0, "user_id": "2561940434", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 4, "like_count": 4, "quote_count": 0}}, "text": "1/ The investor update from $ARCT was directionally promising and ARCT-021 still has the potential to be the best in class #COVID19  #vaccine. Positives: 1) They have dosed all 500 patients for phase 2. That was much faster than phase 1/ 2.", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}